Page last updated: 2024-09-03

agrimophol and Bone Loss, Osteoclastic

agrimophol has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cao, J; Cheng, Z; Gao, Y; Lin, H; Sun, WC; Wang, HB; Wang, S; Wei, C; Xu, Z; Zhang, C	1

Other Studies

1 other study(ies) available for agrimophol and Bone Loss, Osteoclastic

Article	Year
Agrimophol suppresses RANKL-mediated osteoclastogenesis through Blimp1-Bcl6 axis and prevents inflammatory bone loss in mice. International immunopharmacology, 2021, Volume: 90 Topics: Actins; Animals; Bone Resorption; Cell Differentiation; Cells, Cultured; Disease Models, Animal; Lipopolysaccharides; Male; Mice, Inbred C57BL; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Phenols; Positive Regulatory Domain I-Binding Factor 1; Proto-Oncogene Proteins c-bcl-6; RANK Ligand; Signal Transduction	2021

Article

Year

Agrimophol suppresses RANKL-mediated osteoclastogenesis through Blimp1-Bcl6 axis and prevents inflammatory bone loss in mice.

International immunopharmacology, 2021, Volume: 90

Topics: Actins; Animals; Bone Resorption; Cell Differentiation; Cells, Cultured; Disease Models, Animal; Lipopolysaccharides; Male; Mice, Inbred C57BL; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Phenols; Positive Regulatory Domain I-Binding Factor 1; Proto-Oncogene Proteins c-bcl-6; RANK Ligand; Signal Transduction

2021